Literature DB >> 11497249

uPA and uPAR contribute to NK cell invasion through the extracellular matrix.

G Al-Atrash1, R P Kitson, Y Xue, A P Mazar, M H Kim, R H Goldfarb.   

Abstract

BACKGROUND: The urokinase plasminogen activator (uPA) system has been implicated in cellular invasiveness of tumor cells and immune cells. Herein we provide evidence for the production by natural killer (NK) cells of both uPA and its receptor (uPAR).
MATERIALS AND METHODS: Western blot analysis, RTPCR, casein/plasminogen zymography, and fluorescence microscopy were employed to detect uPA and uPAR on NK cells. NK cell invasiveness was examined using Matrigel invasion assays.
RESULTS: NK cell uPA appeared at its characteristic molecular weights, is enzymatically active in casein/plasminogen zymography, and is recognized by monoclonal antibodies. uPAR was detected by RTPCR and fluorescence microscopy. Matrigel invasion assays demonstrated an active role of uPA in NK cell invasion.
CONCLUSION: The uPA system contributes to extracellular matrix (ECM) degradation by NK cells, which may be essential for NK cell accumulation into metastases, and may be prerequisite for their killing of tumor cells following NK cell adoptive transfer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11497249

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  Matrix metalloproteinase-1 produced by human CXCL12-stimulated natural killer cells.

Authors:  Seiji Goda; Hiroshi Inoue; Hisanori Umehara; Michihiko Miyaji; Yutaka Nagano; Nari Harakawa; Hisao Imai; Peter Lee; James B Macarthy; Takashi Ikeo; Naochika Domae; Yoji Shimizu; Joji Iida
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

2.  Integrin alpha6 cleavage: a novel modification to modulate cell migration.

Authors:  Sangita C Pawar; Manolis C Demetriou; Raymond B Nagle; G Tim Bowden; Anne E Cress
Journal:  Exp Cell Res       Date:  2007-01-17       Impact factor: 3.905

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.